Apert Syndrome, also known as acrocephalosyndactyly type 1, is a rare genetic disorder characterized by abnormal growth and development of the skull, face, hands, and feet. It is named after the French physician Eugène Apert, who first described the condition in the early 20th century.
Synonyms for Apert Syndrome include:
Individuals with Apert Syndrome typically have a characteristic appearance, including a high, prominent forehead, wide-set and bulging eyes, a beaked nose, and a small upper jaw. The condition also affects the hands and feet, causing fusion of the fingers and toes, known as syndactyly. Additionally, individuals may experience hearing loss, dental abnormalities, and developmental delays.
Apert Syndrome is caused by mutations in the FGFR2 gene, which plays a crucial role in the development of bones and connective tissues. These mutations result in the premature fusion of certain skull bones, leading to the characteristic features of the syndrome.
Treatment for Apert Syndrome often involves a multidisciplinary approach, addressing the various medical, surgical, and developmental needs of the individual. Surgical interventions may be required to correct craniofacial abnormalities, release fused fingers or toes, and manage other associated complications.
While Apert Syndrome is a lifelong condition, with appropriate medical care and support, individuals with the syndrome can lead fulfilling lives and achieve their full potential.